Amylyx Pharmaceuticals, Inc.
AMLX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001658551
In the last 90 days, Amylyx Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 6 sales; 206 institutions reported holding it in 13F filings for Q2 2026, worth $2.07B in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Amylyx Pharmaceuticals, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 95
- +17 vs. Q2 2022
- Shares held
- 37.3M
- +10.6M (+40.0%) vs. Q2 2022
- Total value
- $1.05B
- +$532.3M (+103.8%) vs. Q2 2022
- New holders
- 33
- 38 more added
- Sold out
- 16
- 20 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AMLX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 206 | $2.07B |
| Q1 2026 | 171 | $1.59B |
| Q4 2025 | 180 | $1.36B |
| Q3 2025 | 169 | $1.49B |
| Q2 2025 | 131 | $523.6M |
| Q1 2025 | 136 | $261.6M |
| Q4 2024 | 122 | $188.3M |
| Q3 2024 | 110 | $140.8M |
| Q2 2024 | 119 | $82.9M |
| Q1 2024 | 143 | $141.5M |
| Q4 2023 | 178 | $887.4M |
| Q3 2023 | 170 | $1.08B |
| Q2 2023 | 154 | $1.18B |
| Q1 2023 | 147 | $1.51B |
| Q4 2022 | 133 | $1.79B |
| Q3 2022 | 95 | $1.05B |
| Q2 2022 | 78 | $512.9M |
| Q1 2022 | 72 | $299.9M |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Amylyx Pharmaceuticals, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Tri Locum Partners LP | 0 | $0 | 0.00% | −80,459−100.0% | Sold out |
| Artal Group S.A. | 0 | $0 | 0.00% | −75,000−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −36,003−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −34,500−100.0% | Sold out |
| Picton Mahoney Asset Management | 0 | $0 | 0.00% | −23,200−100.0% | Sold out |
| HAP Trading, LLC | 0 | $0 | 0.00% | −15,322−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −5,525−100.0% | Sold out |
| PEAK6 Investments LLC | 0 | $0 | 0.00% | −1,500−100.0% | Sold out |
| Glassman Wealth Services | 0 | $0 | 0.00% | −39−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −19−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −21−100.0% | Sold out |